Skip to content
MedGenome US is now Signios Bio — same team, renewed identity.
Now offering 10x Xenium Spatial services in Foster City, CA.
Olink Reveal proteomics: 1,000+ protein biomarkers from just 4 μL of sample.
PacBio Revio long-read sequencing now available for structural variant resolution.
New: Illumina StrataMap 15x50mm spatial slide.
  • Login
  • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • All Services
    • Transcriptomics Services
    • RNA Sequencing
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • Immune Profiling
    • Premade Library Sequencing
    • Long Read Services
    • Genomics Services (WGS/WES)
    • Oncology Panel Sequencing
    • Proteomics Services
    • Epigenomics
  • Multiomics Solutions
    • Multiomics Overview
    • Academics and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical and Diagnostics Laboratories
    • Contract Research Organizations
  • Bioinformatics
    • Bioinformatics Overview
    • WES Analysis
    • RNA Analysis
  • SeqProβ
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
    • FAQs
    • Referral Program
  • Company
    • About
    • News & Events
    • Grants
    • Careers
    • Certified Service Provider
    • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • All Services
    • Transcriptomics Services
    • RNA Sequencing
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • Immune Profiling
    • Premade Library Sequencing
    • Long Read Services
    • Genomics Services (WGS/WES)
    • Oncology Panel Sequencing
    • Proteomics Services
    • Epigenomics
  • Multiomics Solutions
    • Multiomics Overview
    • Multiomics – Academics and Research Institutes
    • Multiomics – Pharmaceutical & Biotechnology Companies
    • Multiomics – Clinical & Diagnostics Laboratories
    • Multiomics – Contract Research Organizations
  • Bioinformatics Solutions
    • Bioinformatics Overview
    • WES Analysis
    • RNA Analysis
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
  • Company
    • About
    • News & Events
    • Careers
    • Certified Service Provider
    • Contact
  • Login

2024

Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma

September 10, 2024

Identification of nine novel HLA alleles by next-generation sequencing in individuals from India

September 6, 2024

GNE Myopathy: Genotype – Phenotype Correlation and Disease Progression in an Indian Cohort

September 2, 2024

Extending HLA allele sequences using next-generation sequencing technology

August 30, 2024

Epidemiological characteristics and molecular identification of Plasmodium species among cases of imported malaria in Kuwait during the COVID-19 pandemic

August 19, 2024

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India

July 19, 2024

rAbDesFlow: a novel workflow for computational recombinant antibody design for healthcare engineering

July 13, 2024

CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice

July 5, 2024

Phenotype-Genotype Correlation of a Cohort of Patients with Congenital Myopathy: A Single Centre Experience from India

July 2, 2024

Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy

July 1, 2024
Post pagination
← Previous 1 2 3 Next →
Scientist-led NGS & multiomics services
Locations:
US:

Signios Biosciences
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

India:
MedGenome Labs Ltd.
  • Sequencing Services
  • Multiomics Solutions
  • Bioinformatics Solutions
  • Resources
  • Company
  • Login
  • Contact

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.

 

© 2026 SIGNIOSBIO. All Rights Reserved.